SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing heightened volatility amid active community discussions regarding upcoming Supreme Court rulings on tariffs and geopolitical developments that could significantly impact global markets. Investors are weighing the potential effects of proposed defense budget increases and mixed economic signals, leading to divided sentiment between those anticipating further market advances and others bracing for a correction. This backdrop is driving cautious trading as market participants assess the interplay of policy shifts and economic data.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is a top trend amidst a recent stock downturn, allowing Alphabet to surpass its market capitalization and sparking investor debate over its AI strategy relative to competitors. News of JPMorgan taking over its credit card business is also in focus, with the community split between buying the dip before upcoming earnings and concerns about innovation, including the Vision Pro headset's reception.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is a focal point of discussion amidst recent, highly contentious events involving an ICE agent in Minneapolis, with former President Trump's comments further fueling the debate. The community is deeply divided, passionately discussing aspects of law enforcement conduct, civilian compliance, and broader political accountability, directly impacting sentiment around the media group.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy is trending following a key DOE agreement for Project TETRA, advancing its Integral Molten Salt Reactor pilot towards construction and operation. The community views this as a significant de-risker, drawing comparisons to peer OKLO's growth trajectory and highlighting nuclear's role in meeting escalating energy demands, particularly from AI infrastructure.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is a top trending stock after MSCI decided against excluding digital asset treasury firms from its indexes, a move widely seen as removing a significant overhang for the company. Bulls are now anticipating a potential short squeeze and substantial upside, while skeptics remain cautious, pointing to ongoing share dilution and Bitcoin's recent price volatility as continuing risks.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is experiencing substantial bullish momentum, largely driven by its recent Robinhood listing and perceived decoupling from broader market trends. The community is actively discussing potential short squeezes and significant future gains, anticipating that upcoming developments like the Goliath Mainnet and Chain's ISO 20022 upgrade will further cement its position for institutional adoption.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience (RGC) is trending due to an exceptionally high short borrow rate, reportedly exceeding 600%, coupled with a scarcity of shares available for shorting. This has ignited community discussion around a potential short squeeze, with many drawing comparisons to past parabolic runs in other low-float stocks, despite some viewing it as a speculative "casino play."

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics (GLUE) is currently trending due to compelling interim Phase 1 data for its molecular glue degrader MRT-8102, which showed significant reductions in inflammatory markers. While many in the community are celebrating this as strong validation for the platform and anticipate further upside, others are cautiously discussing a potential or announced share offering that could lead to dilution, creating a divided sentiment amidst high short interest.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is actively trending amidst market volatility spurred by President Trump's varying statements on defense industry corporate policies and a proposed increase in the U.S. military budget. This follows a rapid rebound from initial dips, with the community now focused on a significant agreement to expand PAC-3 missile production and the broader context of elevated global defense spending.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is generating significant buzz following the recent regulatory approval and immediate market launch of its groundbreaking therapy for a rare and fatal condition. The community is highly optimistic, anticipating substantial revenue and analyst upgrades, as this novel treatment is poised to become the standard of care, displacing less safe alternatives and intensifying pressure on short positions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CENTA Central Garden &amp; Pet reports Q4 adjusted EPS (18c) vs 8c last year 
 
Reports Q4 revenue $669M, consensus $711.24M. &quot;We have a lot to be proud of this year. We increased non-GAAP EPS, continued margin expansion, made significant progress on our Cost and Simplicity program, and achieved strong profits in our Pet segment and record cash flow for the company. We accomplished this despite continued soft demand across our Pet segment, in particular in durable pet products, and a difficult garden season,&quot; said Niko Lahanas, Central Garden &amp; Pet&#39;s new CEO. &quot;While we expect the external environment to remain challenging, I am confident we have the right strategy and people in place to deliver profitable growth in fiscal 2025 and for the long term.&quot;

StockTwits Web

Central Garden & Pet Co. - Ordinary Shares - Class A

 Central Garden & Pet reports Q4 adjusted EPS (18c) vs 8c last year 
 
Reports Q4 revenue $669M, consensus $711.24M. "We have a lot to be proud of this year. We increased non-GAAP EPS, continued margin expansion, made significant progress on our Cost and Simplicity program, and achieved strong profits in our Pet segment and record cash flow for the company. We accomplished this despite continued soft demand across our Pet segment, in particular in durable pet products, and a difficult garden season," said Niko Lahanas, Central Garden & Pet's new CEO. "While we expect the external environment to remain challenging, I am confident we have the right strategy and people in place to deliver profitable growth in fiscal 2025 and for the long term."